| (in millions $) | 1 May 2025 | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | ||||
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | ||||
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | ||||
| Shareholders' equity | ||||
| Retained earnings | ||||
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2025 | 31 Jan 2024 | 31 Jan 2023 | 30 Mar 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2669 | |||
| Short term investments | $934.1 | |||
| Net receivables | $76.4 | $59.7 | $43.5 | |
| Inventory | $6.2 | $6 | $4.3 | |
| Total current assets | $5827.1 | $5911.4 | $5475.1 | |
| Long term investments | ||||
| Property, plant & equipment | $11013.5 | $10118 | $9228.8 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $17175.6 | $16405.9 | $15149.8 | |
| Current liabilities | ||||
| Accounts payable | $792.2 | $1065.5 | $1029 | |
| Deferred revenue | ||||
| Short long term debt | $998.5 | |||
| Total current liabilities | $6400.6 | $7421.6 | $5398.7 | |
| Long term debt | $2657.4 | $3016.3 | $3714.6 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $9561.4 | $10762.9 | $9604.5 | |
| Shareholders' equity | ||||
| Retained earnings | $6203 | $4256.2 | $2880.9 | |
| Other shareholder equity | $266 | $31 | $1329.4 | |
| Total shareholder equity | $5545.3 | |||
| (in millions $) | 30 Jul 2025 | 1 May 2025 | 31 Jan 2025 | 30 Oct 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | ||||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Mar 2022 | 30 Mar 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4800.9 | $1635.8 | ||
| Cost of revenue | $4009.8 | $1702.7 | ||
| Gross Profit | $791.1 | -$66.9 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $411.3 | $201.5 | ||
| Total operating expenses | $5140.5 | $2475.2 | ||
| Operating income | -$339.6 | -$839.4 | ||
| Income from continuing operations | ||||
| EBIT | -$339.6 | -$839.4 | ||
| Income tax expense | -$189 | -$93.6 | ||
| Interest expense | -$91.4 | -$53.8 | ||
| Net income | ||||
| Net income | -$240.8 | -$1015.1 | ||
| Income (for common shares) | -$240.8 | -$1015.1 | ||
| (in millions $) | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$1560.4 | -$1258.2 | -$893.7 | -$1873 |
| Financing activities | ||||
| Dividends paid | -$199.5 | |||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$1326.3 | -$1100.6 | -$1089.6 | -$23.1 |
| Effect of exchange rate | $4.9 | -$7.6 | $4.1 | |
| Change in cash and equivalents | $276.1 | -$1080.7 | -$338.8 | -$644.5 |
| (in millions $) | 1 May 2024 | 1 May 2023 | 30 Mar 2022 | 30 Mar 2021 |
|---|---|---|---|---|
| Net income | -$240.8 | -$1015.1 | ||
| Operating activities | ||||
| Depreciation | $719.4 | $571 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $1940.5 | -$2448 | ||
| Investing activities | ||||
| Capital expenditures | -$1181.6 | -$294.7 | ||
| Investments | -$468.6 | $741.7 | ||
| Total cash flows from investing | -$1560.4 | -$1901.2 | -$1414.4 | $937.1 |
| Financing activities | ||||
| Dividends paid | -$199.5 | |||
| Sale and purchase of stock | ||||
| Net borrowings | -$583.3 | $1201.5 | ||
| Total cash flows from financing | -$1326.3 | -$1054 | -$536.5 | $1622.5 |
| Effect of exchange rate | $4.9 | -$5.5 | $28.7 | -$27.3 |
| Change in cash and equivalents | $276.1 | $930.3 | $18.3 | $84.3 |
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |